Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Non Small Cell Lung Cancer|Head and Neck Squamous Cell Carcinoma|Triple Negative Breast Cancer|Cutaneous Squamous Cell Carcinoma|Hormone Receptor Positive Breast Carcinoma|Small Bowel Cancer|Esophageal Cancer|Colorectal Cancer|Diffuse Large B Cell Lymphoma|Hodgkin Lymphoma|Burkitt Lymphoma|T-cell Lymphoma
Interventions: DRUG: IMT-009
Sponsor: Immunitas Therapeutics